Phase 4 Migraine Trial, Recruiting NCT07022496 Sponsor: Ain Shams University Condition: Migraine
Back to Migraine

Phase 4 Migraine Trial, Recruiting

NCT07022496
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with migraine (with or without aura, episodic, or chronic) according to standard medical diagnostic guidelines (known as ICHD-3)

Who may not be able to join:

  • People with a history of irregular heart rhythms, high blood pressure, reduced blood supply to the heart, active stomach ulcers, inflammatory bowel disease, obsessive compulsive disorder, kidney failure, liver failure, sleep disorders, intellectual disability, or a history of substance abuse that would make it difficult to participate in the study
  • People who are pregnant or breastfeeding
  • People whose headaches are caused by cluster headaches, nerve pain conditions in the face or throat (trigeminal or glossopharyngeal neuralgia), a head injury, a disorder of the skull or brain, a blood vessel problem, an infection, or a growth or mass in the brain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 00201128215952

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
26 April 2023
Est. completion
1 July 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

To reduce the severity of migraine attack

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov